Delivery Order SPE2DE24D0013-SPE2D626F87T2
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. on December 8, 2025, with an ultimate completion date of December 15, 2025. This delivery order, designated XPRS4PLEX-10, represents a small procurement of diagnostic reagents and test kits for Cepheid's GeneXpert diagnostic platform. The contract carries no set-aside designation and is being performed at Cepheid's headquarters location in Sunnyvale, California. As a leading federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $27,650.40 firm fixed-price delivery order to Cepheid Inc. on September 18, 2025, with completion targeted for September 25, 2025. The delivery order, identified as XPRSMVP-10 (Contract Number 4569505244), is being performed at Cepheid's headquarters in Sunnyvale, California. This award carries no set-aside designation and represents a discrete procurement under the company's broader federal contracting relationship with...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,337.50 to Cepheid Inc. on December 18, 2025, with an ultimate completion date of January 5, 2026. This firm fixed-price delivery order, issued under contract GXMRSA-NXG-10, carries no set-aside designation and will be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid, a leading manufacturer of advanced molecular diagnostic systems and reagents, has established itself as a primary federal...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $2,024 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 13, 2026. This delivery order, designated XPRSTREPA-10 (4570410034), carries no set-aside designation and represents procurement of diagnostic testing supplies and reagents from Cepheid's established federal product portfolio....
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on December 29, 2025, with an ultimate completion date of January 6, 2026. The contract, designated as XPRSMVP-10 and issued under a firm fixed-price arrangement with no set-aside designation, supports the agency's procurement of molecular diagnostic solutions. As a leading federal supplier of advanced diagnostic systems and reagents, Cepheid...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- The Defense Logistics Agency Medical Supply Chain issued a delivery order valued at $1,843.36 to Cepheid Inc. on December 1, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order, designated as XPRSMVP-10, carries no set-aside designation and represents a small procurement under the agency's broader medical supply chain contracting framework. Cepheid, headquartered in Sunnyvale, California, is a leading federal supplier of molecular diagnostic systems...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $5,440 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 12, 2025, with an ultimate completion date of December 19, 2025. This delivery order, designated XPRS4PLEX-10, represents a non-set-aside procurement executed under Cepheid's established contracting relationship with the federal healthcare and defense procurement system. The award...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $52,387.20 to Cepheid Inc. on September 26, 2025, with an ultimate completion date of October 3, 2025. This firm fixed-price delivery order (contract number 4569624736, XPRS4PLEX-10) carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The award represents a discrete purchase under one of Cepheid's larger indefinite delivery...
- This delivery order, valued at $19,375.00, was awarded to Cepheid Inc. on December 8, 2025, by the Defense Logistics Agency Medical Supply Chain, with ultimate completion scheduled for December 15, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, issued under the XPRS4PLEX-10 procurement vehicle. Cepheid, headquartered in Sunnyvale, California, is a leading manufacturer of advanced molecular diagnostic systems and reagents specializing in rapid infectious...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F87T2Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,530.08 to Cepheid Inc. on January 7, 2026, with an ultimate completion date of January 14, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, represents a relatively modest procurement within Cepheid's broader federal contract portfolio. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as an established federal supplier. Performance will take place at Cepheid's headquarters in Sunnyvale, California. This delivery order is issued under a larger contracting vehicle managed by the Defense Logistics Agency's Medical Supply Chain division, which procures diagnostic testing supplies, test kits, and reagents from qualified vendors. Cepheid, a specialized manufacturer of advanced molecular diagnostic systems including the GeneXpert platform, has established itself as a primary federal supplier of infectious disease diagnostics across multiple government agencies, including the Department of Veterans Affairs, Defense Health Agency, and Indian Health Service. The company's federal contracts demonstrate extensive capability in providing rapid molecular diagnostic testing for conditions such as COVID-19, influenza, and respiratory pathogens, supported by firm fixed-price delivery orders ranging from modest supply orders to multi-million-dollar comprehensive agreements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.5k | 1/6/26 |